End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.17 CNY | -0.08% | +2.11% | -3.44% |
03:11pm | Shanghai Fosun Pharmaceutical Unit Secures China Nod to Sell Schizophrenia Drug | MT |
07/05 | US FDA Grants Clinical Trial Approval for Fosun Unit's Gastric Cancer Tablets | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 7.99B | |
+32.75% | 698B | |
+26.51% | 568B | |
-4.48% | 358B | |
+19.14% | 328B | |
+3.87% | 283B | |
+16.44% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+7.86% | 165B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Fosun Pharma Unit Gets China OK for Phase I Trial for Solid Tumor Drug